Expertise in
27
conditions

Estibaliz Lazaro

Pessac-sur-dordogne, FR 
Expertise in
27
conditions
Pessac-sur-dordogne, FR 

Overview

Estibaliz Lazaro practices practicing medicine in Pessac-sur-dordogne, France.

Ms. Lazaro is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses VEXAS Syndrome, Systemic Lupus Erythematosus (SLE), Vasculitis, Splenectomy, and Kidney Transplant.

She is actively involved in clinical research, co-authoring 226 peer reviewed articles and participating in 10 clinical trials.

Gender

Female

Locations

Pessac-sur-dordogne, 33604, France
Other Locations
Bordeaux, France
CHU
Rouen, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Soluble CD95 Ligand Role in the Pathophysiology of ANCA Associated Vasculitis
Soluble CD95 Ligand Role in the Pathophysiology of ANCA Associated Vasculitis
Enrollment Status: Completed
Publish Date: August 17, 2026
Intervention Type: Biological
Study Phase: Not Applicable
Real-life Evaluation of the Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection in Patients Receiving Long-term Treatment for Systemic Lupus Erythematosus and/or Gougerot's Disease
Real-life Evaluation of the Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection in Patients Receiving Long-term Treatment for Systemic Lupus Erythematosus and/or Gougerot's Disease
Enrollment Status: Completed
Publish Date: August 10, 2026
Intervention Type: Diagnostic test, Other
Study Phase: Not Applicable
Anemil Trial : Phase I/II Clinical Trial Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment
Anemil Trial : Phase I/II Clinical Trial Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment
Enrollment Status: Terminated
Publish Date: May 22, 2026
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Involvement of Immune Cells Derived From the Intestine in Sjogren's Syndrome
Involvement of Immune Cells Derived From the Intestine in Sjogren's Syndrome
Enrollment Status: Completed
Publish Date: May 20, 2026
Intervention Type: Biological
Study Drugs: Blood sample, Biopsy of the labial salivary gland
Study Phase: Not Applicable
Vasculopathy, Inflammation and Systemic Sclerosis: The Role of Endothelial Cell Activation and OX40/OX40L in Modulation of T Lymphocyte Activation
Vasculopathy, Inflammation and Systemic Sclerosis: The Role of Endothelial Cell Activation and OX40/OX40L in Modulation of T Lymphocyte Activation
Enrollment Status: Completed
Publish Date: May 14, 2026
Intervention Type: Biological
Study Phase: Not Applicable
Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous
Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous
Enrollment Status: Completed
Publish Date: May 14, 2026
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Dietary Phytoestrogens in Blood and Urine of Female Patient With Acute Systemic Lupus Erythematosus
Dietary Phytoestrogens in Blood and Urine of Female Patient With Acute Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: May 14, 2026
Intervention Type: Other
Study Phase: Not Applicable
Intra-nodal Injection of Gentamicin for the Treatment of Suppurated Cat Scratch Disease's Lymphadenitis: A Randomized Controlled Study
Intra-nodal Injection of Gentamicin for the Treatment of Suppurated Cat Scratch Disease's Lymphadenitis: A Randomized Controlled Study
Enrollment Status: Completed
Publish Date: March 25, 2026
Intervention Type: Drug
Study Drug: Gentamicin
Study Phase: Phase 3
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases
Enrollment Status: Active_not_recruiting
Publish Date: February 03, 2026
Intervention Type: Biological, Other, Behavioral
Study Phase: Not Applicable
O-GlcNAcylation Role in the Pathophysiology of Systemic Lupus Erythematosus
O-GlcNAcylation Role in the Pathophysiology of Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: January 19, 2024
Intervention Type: Biological
Study Phase: Not Applicable
View 9 Less Clinical Trials

226 Total Publications

From CD20 to CD19: the shift from cautious to deeper B-cell depletion in autoimmune diseases.
From CD20 to CD19: the shift from cautious to deeper B-cell depletion in autoimmune diseases.
Journal: The Journal of allergy and clinical immunology
Published: May 26, 2026

Frequently Asked Questions about Estibaliz Lazaro

Is Estibaliz Lazaro a top-rated expert for VEXAS Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Estibaliz Lazaro is classified as an Elite expert for VEXAS Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Estibaliz Lazaro participate in research or clinical trials?

Yes. Estibaliz Lazaro has published 226 articles and abstracts on conditions like VEXAS Syndrome. You can view a list of Estibaliz Lazaro's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Lazaro's expertise for a condition
ConditionClose
View All 23 Advanced Conditions
View All 82 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile